Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

CSE/RAMM stock hub

CSE/RAMM has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

CSE/RAMMis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

1.2M

Canadian Securities Exchange

Market data

Live price

Current market quote for this ticker.

Current price

CSE/RAMM

In the news

Latest news · CSE/RAMM

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 11P50 15.6P75 25.4

Trailing P/En/a

P25 7.4P50 15.6P75 34.3

ROE-99.8

P25 -121.5P50 -40.9P75 0.5

ROIC-30.2

P25 -72.5P50 -16P75 1.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All CSE/RAMM market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

170

Groups with data

Currency

CAD

Showing 170 of 170 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Canada
Country code	CA
Enterprise value	CAD 269,823
Exchange	Canadian Securities Exchange
Financial currency	CAD
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	CA75150G1046
Last refreshed	2026-05-10
Market cap	CAD 1.2M
Price	CAD 0.01
Price currency	CAD
Sector	Healthcare
Sic	2834
Symbol	cse/RAMM
Website	https://www.wearerammpharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-724.19%
EV Earnings	-0.03x
EV/FCF	-0.24x
EV/Sales	0.11x
FCF yield	-93.01%
P/B ratio	0.24x
P/S ratio	0.47x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-165.68%
EBITDA Margin	-147.53%
Gross margin	29.71%
Gross Profit	CAD 761,566
Gross Profit Growth	-56.47%
Gross Profit Growth Q	-39.01%
Gross Profit Growth3 Y	0.87%
Gross Profit Growth5 Y	-7.92%
Net Income	CAD -8.6M
Net Income Growth Quarters	5%
Net Income Growth Years	1%
Pretax Margin	-333.24%
ROA	-22.12
Roa5y	-15.1
ROCE	-86.81
ROE	-99.83
Roe5y	-50.7
ROIC	-30.19

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-33.35%
Cagr3y	-47.72%
Cagr5y	-59.7%
EPS Growth Quarters	5
EPS Growth Years	1
Revenue Growth	-41.7x
Revenue Growth Q	-78.94x
Revenue Growth Years	0x
Revenue Growth3 Y	-15.72x
Revenue Growth5 Y	-13.02x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CAD 0.21
Assets	CAD 8.4M
Cash	CAD 985,374
Current Assets	CAD 2.3M
Current Liabilities	CAD 3.6M
Debt	CAD 61,301
Debt Equity	CAD 0.01
Debt FCF	CAD -0.06
Equity	CAD 4.9M
Interest Coverage	-17.7
Liabilities	CAD 3.6M
Long Term Assets	CAD 6.1M
Long Term Liabilities	CAD 0
Net Cash	CAD 924,073
Net Cash By Market Cap	CAD 77.4
Net Cash Growth	226.82%
Net Debt Equity	CAD -0.19
Tangible Book Value	CAD 4.9M
Tangible Book Value Per Share	CAD 0.04
WACC	21.91

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.66
Inventory Turnover	1.25
Net Working Capital	CAD -2.1M
Quick ratio	0.4
Working Capital	CAD -1.2M
Working Capital Turnover	CAD 26.54

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-33.33%
200-day SMA	0.04
3Y total return	-85.71%
50-day SMA	0.04
50-day SMA vs 200-day SMA	50over200
5Y total return	-98.94%
All Time High	1.19
All Time High Change	-99.16%
All Time High Date	2021-03-15
All Time Low	0.01
All Time Low Change	100%
All Time Low Date	2024-12-16
ATR	0
Beta	0.53
Beta1y	-8.17
Beta2y	-2.33
Ch YTD	-83.33
High	0.01
High52	0.25
High52 Date	2025-11-10
High52ch	-96%
Low	0.01
Low52	0.01
Low52 Date	2026-05-05
Low52ch	0%
Ma50ch	-73.54%
Price vs 200-day SMA	-71.51%
RSI	34.52
RSI Monthly	40.36
RSI Weekly	42.8
Sharpe ratio	1.09x
Sortino ratio	3.6
Tr YTD	-83.33
Tr1m	-50%
Tr1w	-33.33%
Tr3m	-71.43%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CAD -4.2M
Operating margin	-165.7

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	81,869,317%
Net Borrowing	-101,255
Shares Insiders	31.43%
Shares Institutions	0.01%
Shares Out	119,389,317
Shares Qo Q	0%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CAD -1.1M
Average Volume	89,506.45x
Bv Per Share	0.04
CAPEX	CAD 25,000
Ch1m	-50
Ch1w	-33.33
Ch1y	-33.33
Ch3m	-71.43
Ch3y	-85.71
Ch5y	-98.94
Ch6m	-33.33
Change	-33.33%
Change From Open	0
Close	0.02
Days Gap	-33.33
Depreciation Amortization	465,338
Dollar Volume	3,450
Earnings Date	2026-06-26
EBIT	CAD -4.2M
EBITDA	CAD -3.8M
EPS	CAD -0.07
F Score	2
FCF	CAD -1.1M
FCF EV Yield	-411.54x
FCF Per Share	CAD -0.01
Financing CF	-109,843
Fiscal Year End	October
Founded	1,987
Income Tax	CAD 104,533
Investing CF	1,789,418
Is Primary Listing	1
Last Earnings Date	2026-02-27
Last Report Date	2026-01-31
Ma150	0.03
Ma150ch	-61.54%
Ma20	0.02
Ma20ch	-50%
Net CF	504,938
Next Earnings Date	2026-06-26
Open	0.01
Ppne	6,110,640
Price Date	2026-05-07
Ptbv Ratio	0.24
Relative Volume	3.85x
Revenue	2,563,221x
Tax By Revenue	4.08x
Tr6m	-33.33%
Volume	345,000
Z Score	-13.42

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does CSE/RAMM pay a dividend?

Capital-return profile for this ticker.

Performance

CSE/RAMM stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns CSE/RAMM?

Insider, institutional, and short-interest positioning.

Institutional ownership

+0.0%

Share of float held by funds and institutions

Insider ownership

+31.4%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

n/a

Negative means the company is buying back shares.

Technical

CSE/RAMM momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

34.5

Neutral momentum band

Price vs 200-day MA

-71.5%

50/200-day relationship not available

Beta (5Y)

0.53

Less volatile than the market

Sharpe ratio

1.09

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About CSE/RAMM

Hub-level FAQ points readers to the deeper analysis pages.

What is the current cse/RAMM stock rating?

cse/RAMM is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full cse/RAMM analysis?

The full report lives at /stocks/cse/RAMM/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for cse/RAMM?

The latest report frames cse/RAMM around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the cse/RAMM page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.